EXPERIENCE IN THE USE OF RECOMBINANT ACTIVATED COAGULATION FACTOR VII IN THE TREATMENT OF MASSIVE OBSTETRIC BLEEDING AND THE PLACENTA PREVIA AND ACCRETA
The article presents a clinical observation of treatment of massive obstetric bleeding in pregnant (gestational age 35 weeks) with placenta and accreta using recombinant activated factor VII coagulation – Coagil-VII (Russia, “Generium”). In operation: laparotomy, caesarean section in the lower uter...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1427 |